Incyte Corp (NASDAQ: INCY) on Monday, soared 3.39% from the previous trading day, before settling in for the closing price of $95.41. Within the past 52 weeks, INCY’s price has moved between $53.56 and $109.28.
Healthcare Sector giant saw their annual sales slid by -40.36% over the last five years. The company achieved an average annual earnings per share of 523.99%. With a float of $194.23 million, this company’s outstanding shares have now reached $196.13 million.
Incyte Corp (INCY) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Incyte Corp is 1.07%, while institutional ownership is 103.66%. The most recent insider transaction that took place on Dec 15 ’25, was worth 18,205,930. Before that another transaction happened on Dec 10 ’25, when Company’s EVP & Chief Scientific Officer sold 5,553 for $95.58, making the entire transaction worth $530,756. This insider now owns 60,266 shares in total.
Incyte Corp (INCY) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 1.43 earnings per share (EPS) for the period falling under the consensus outlook (set at 1.55) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 523.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 105.38% during the next five years compared to -40.36% drop over the previous five years of trading.
Incyte Corp (NASDAQ: INCY) Trading Performance Indicators
Incyte Corp (INCY) is currently performing well based on its current performance indicators. A quick ratio of 3.13 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.02. Likewise, its price to free cash flow for the trailing twelve months is 16.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.96, a number that is poised to hit 1.93 in the next quarter and is forecasted to reach 7.78 in one year’s time.
Technical Analysis of Incyte Corp (INCY)
Analysing the last 5-days average volume posted by the [Incyte Corp, INCY], we can find that recorded value of 2.25 million was better than the volume posted last year of 1.96 million. As of the previous 9 days, the stock’s Stochastic %D was 29.23%.
During the past 100 days, Incyte Corp’s (INCY) raw stochastic average was set at 73.13%, which indicates a significant increase from 36.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.12 in the past 14 days, which was higher than the 2.65 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $96.77, while its 200-day Moving Average is $77.26. Now, the first resistance to watch is $100.23. This is followed by the second major resistance level at $101.81. The third major resistance level sits at $104.19. If the price goes on to break the first support level at $96.27, it is likely to go to the next support level at $93.89. Now, if the price goes above the second support level, the third support stands at $92.31.
Incyte Corp (NASDAQ: INCY) Key Stats
Market capitalization of the company is 19.37 billion based on 196,323K outstanding shares. Right now, sales total 4,241 M and income totals 32,610 K. The company made 1,366 M in profit during its latest quarter, and 424,170 K in sales during its previous quarter.
